Published in J Pharmacol Exp Ther on November 18, 2014
Effects of repeated morphine on intracranial self-stimulation in male rats in the absence or presence of a noxious pain stimulus. Exp Clin Psychopharmacol (2015) 0.80
Analysis of inflammation-induced depression of home cage wheel running in rats reveals the difference between opioid antinociception and restoration of function. Behav Brain Res (2016) 0.80
Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats. Eur J Pharmacol (2014) 0.79
Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats. Behav Pharmacol (2016) 0.77
Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats. J Pharmacol Exp Ther (2015) 0.76
Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner. PLoS One (2015) 0.75
Assessment of Behavioral Disruption in Rats with Abdominal Inflammation Using Visual Cue Titration and the Five-choice Serial-reaction Time Task. Anesthesiology (2017) 0.75
Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore (1994) 16.38
Depression and pain comorbidity: a literature review. Arch Intern Med (2003) 11.34
Animal models of pain: progress and challenges. Nat Rev Neurosci (2009) 4.71
A common neurobiology for pain and pleasure. Nat Rev Neurosci (2008) 3.45
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol (1994) 2.70
Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol (1977) 2.61
Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl) (2004) 2.35
Summary health statistics for U.S. adults: National Health Interview Survey, 2002. Vital Health Stat 10 (2004) 2.24
Forebrain pain mechanisms. Brain Res Rev (2008) 1.89
Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther (2006) 1.75
Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain. Anesthesiology (2004) 1.43
The epidemiology of pain in depression. Hum Psychopharmacol (2004) 1.43
Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia. Pain (2012) 1.42
Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev (2014) 1.37
mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol (1997) 1.36
Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther (1994) 1.36
Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain (2009) 1.32
Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus. J Pharmacol Exp Ther (1998) 1.30
Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc (2008) 1.26
Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology (2008) 1.22
Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats. J Pain (2013) 1.18
Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J Pharmacol Exp Ther (1992) 1.17
Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J Pain (2006) 1.16
Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharmacol (2011) 1.16
Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. J Pharmacol Exp Ther (1993) 1.15
Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology (Berl) (2010) 1.14
Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Life Sci (2009) 1.13
Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement. J Pharmacol Exp Ther (1999) 1.11
The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats. Eur J Pharmacol (2008) 1.09
Persistent pain model reveals sex difference in morphine potency. Am J Physiol Regul Integr Comp Physiol (2006) 1.08
kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. J Pharmacol Exp Ther (1998) 1.06
Differentiation between capsaicin-induced allodynia and hyperalgesia using a thermal operant assay. Behav Brain Res (2006) 1.05
Pain assessment and treatment in the managed care environment. A position statement from the American Pain Society. Case Manager (2002) 1.04
Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor. J Pharmacol Exp Ther (1999) 1.04
Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats. J Pharmacol Exp Ther (2011) 1.03
Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia. Methods Mol Biol (2010) 1.01
Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors. J Pharmacol Exp Ther (2003) 1.00
Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids. Neuropsychopharmacology (2013) 0.98
Role of µ-opioid receptor reserve and µ-agonist efficacy as determinants of the effects of µ-agonists on intracranial self-stimulation in rats. Behav Pharmacol (2012) 0.93
Renal calculi: emergency department diagnosis and treatment. Emerg Med Pract (2011) 0.93
Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor. J Pharmacol Exp Ther (1999) 0.92
Increased analgesic potency of mu agonists after continuous naloxone infusion in rats. J Pharmacol Exp Ther (1991) 0.91
Expression and treatment of pain-related behavioral depression. Lab Anim (NY) (2013) 0.90
Abuse-related effects of µ-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure. Behav Pharmacol (2013) 0.89
Relief of abdominal pain by morphine without altering physical signs in acute appendicitis. Chin Med J (Engl) (2010) 0.88
Pharmacological interaction of opiates with various classes of centrally acting dopaminergic drugs. Drug Metabol Drug Interact (1991) 0.87
Management of pain in the elderly at the end of life. Drugs Aging (2012) 0.85
Analgesic efficacy of a hydrocodone with ibuprofen combination compared with ibuprofen alone for the treatment of acute postoperative pain. J Clin Pharmacol (1997) 0.84
Buprenorphine-naloxone therapy in pain management. Anesthesiology (2014) 0.82
Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine. J Anesth (2001) 0.81
A review of systemic opioids commonly used for labor pain relief. J Midwifery Womens Health (2011) 0.80
Why do emergency providers choose one opioid over another? A prospective cohort analysis. J Opioid Manag (2012) 0.79
Analgesic effects of antidepressants alone and after their local co-administration with morphine in a rat model of neuropathic pain. Pharmacol Rep (2014) 0.78
Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug's relative intrinsic efficacy at the mu receptor. Behav Pharmacol (1996) 0.78
Interaction between Mu and Delta Opioid Receptor Agonists in an Assay of Capsaicin-Induced Thermal Allodynia in Rhesus Monkeys. Pain Res Treat (2012) 0.77
Buprenorphine for chronic pain. J Pain Palliat Care Pharmacother (2013) 0.77
Stress-opioid interactions: a comparison of morphine and methadone. Pharmacol Rep (2009) 0.76
[Analgesic properties of narcotic antagonists]. Arch Invest Med (Mex) (1974) 0.76